Temporal response to bupivacaine bilateral great occipital block in a patient with SUNCT syndrome.
Jesús
J
Porta-Etessam
Maria L
ML
Cuadrado
Lucía
L
Galán
Arturo
A
Sampedro
Cristina
C
Valencia
D000369:Aged, 80 and over; D000588:Amines / Q000627:therapeutic use; D000779:Anesthetics, Local / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D002045:Bupivacaine / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D005157:Facial Pain / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D005260:Female; D007839:Functional Laterality; D000077206:Gabapentin; D006801:Humans; D000077213:Lamotrigine; D009407:Nerve Block / Q000379:methods*; D009777:Occipital Bone / Q000294:innervation; D050798:SUNCT Syndrome / Q000188:drug therapy* / Q000503:physiopathology*; D013127:Spinal Nerves / Q000187:drug effects* / Q000503:physiopathology; D013997:Time Factors; D016896:Treatment Outcome; D014227:Triazines / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
D000588:Amines; D000779:Anesthetics, Local; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D014227:Triazines; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D000077213:Lamotrigine; D002045:Bupivacaine